Feasibility and clinical impact of routine molecular testing of gastrointestinal cancers at a tertiary centre with a multi-gene, tumor-agnostic, next generation sequencing panel-Reference-Cited by-同舟云学术

Feasibility and clinical impact of routine molecular testing of gastrointestinal cancers at a tertiary centre with a multi-gene, tumor-agnostic, next generation sequencing panel

Published:2020-08-21 Issue:12 Volume:59 Page:1438-1446
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Bregni Giacomo¹²,Sticca Tiberio³,Camera Silvia¹²,Akin Telli Tugba¹²,Craciun Ligia³,Trevisi Elena¹²,Pretta Andrea¹²,Kehagias Pashalina²,Leduc Sophia²,Senti Chiara²,Deleporte Amélie¹²,Vandeputte Caroline²,Saad Everardo Delforge⁴⁵,Kerger Joseph¹,Gil Thierry¹,Piccart-Gebhart Martine¹,Awada Ahmad¹^ORCID,Demetter Pieter³,Larsimont Denis³,Hendlisz Alain¹²,Aftimos Philippe¹,Sclafani Francesco¹²

Affiliation:

1. Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium

2. GUTS lab, Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium

3. Department of Pathology and Molecular Biology, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium

4. Dendrix Research, Sao Paulo, Brazil

5. International Drug Development Institute, Louvain-la-Neuve, Belgium

Funder

European Society for Medical Oncology

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine